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Abstract: In the present study, new polymer microspheres of amphotericin B (AmB) were prepared
by a spray drying technique using cyclodextrin polymers (Poly-CD) to improve the solubility and
dissolution of AmB, to prevent in vivo toxic AmB aggregations. Formulations were characterized
through scanning electron microscopy (SEM), Fourier transform infrared spectroscopy (FT-IR),
differential scanning calorimetry (DSC), thermal analysis, Raman spectroscopy, particle size,
drug purity test and in vitro release studies. The analysis indicated that the chemical structure
of AmB remained unchanged in the amorphous solid dispersion, but the structure was changed
from crystalline to amorphous. AmB was completely release from such optimized formulations in
dissolution media in 40 min. This work may contribute to a new generation of spherical amorphous
solid dispersion using a cyclodextrin polymer, which has implications for the possibility of drug
development for oral utilization or as powder aerosols for pulmonary administration.
Keywords: amorphous solid dispersions; amphotericin B; cyclodextrins polymers; spray-drying
1. Introduction
Amphotericin B [AmB] is considered as an old drug with antifungal properties. This active
pharmaceutical ingredient was extracted from Streptomyces nodosus and its chemical synthesis was
discovered in 1970 [1]. In medicine, AmB is used for the treatment of deep or systemic fungal
development induced by an immunosuppressive state of patient which is one of the major causes of
mortality [2].
AmB belongs to class IV in the Biopharmaceutical Classification System, presenting low solubility
(about 1 µg/mL in water) and low membrane permeability [3]. This low solubility is due to the
self-association of AmB molecules above a critical micellar concentration at about 0.2 mg/mL [4].
The long polyene chain measuring 21 Å is responsible for the high absorption between 300 and 450 nm
allowing its dosage using an ultra-violet [UV] spectrophotometer.
Recently, several formulations were described to enhance AmB solubility, such as amorphous
drug nanoparticles [5], carbon nanotubes [6], chitosan microparticles [7], cubosomalnanoparticles [8],
nano-emulsions [9], gelatin nanoparticles [10], polymeric nanoparticles [11], solid lipid nanoparticles [12]
or liposomes [13].
The marketed available preparations of AmB are AmBisome® and Fungizone®. These preparations
are indicated for the intravenous route and Fungizone is also indicated per os. However, the high
interaction of AmB molecules with plasma proteins induces nephrotoxicity [14]. Hepatotoxicity was also
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described at therapeutic doses corroborating with aggregated states of AmB: dimeric or poly-aggregated
forms. These aggregated states of AmB depend on different formulation factors such as pH and the
presence of some excipients [15,16].
To prevent in vivo toxic aggregated forms, the use of cyclodextrins [CD] or derivatives seems
interesting. Indeed, CDs have the ability to form inclusion complexes in their inner cavity with host
molecules preventing aggregation. CD and their derivatives are also known to be efficient solubilizing
agents [17]. CD-based polymers [Poly-CD] were developed in order to increase the solubility of natural
CD or derivatives [18]. In addition, natural CD or Poly-CD as solubilizing agents are considered as
safe for a pharmaceutical use because of their non-toxic composition, mainly based on glucose units.
A new approach is essential to implement the large capacity of this antifungal drug. To avoid
the conventional routes of administration and to enhance the local drug bioavailability, another
alternative is found by inhalation AmB particles to target local action in the lungs. A recent study has
showed interest in using a pulmonary route for administering microparticles and lipid complexes [19].
The results showed a good pulmonary deposition and a lower rate of active substance in the kidney
leading to a reduction of drug nephrotoxicity and an improvement of fungal activity, approximately
1.5-times better than the marketed intravenous preparations. Pharmacokinetic and organ distribution
studies showed that the pulmonary administration may be favorable for a good efficiency by local
action [19].
The aim of this work is to design and evaluate in vitro original formulations of AmB based on
cyclodextrin or derivatives for lung administration.
To reach a targeted release, the design of amorphous solid dispersions using Poly-CD will
be studied.
2. Materials and Methods
2.1. Chemicals and Materials
Amphotericin B as active pharmaceutical ingredient was purchased by Quimdis (Levallois-Perret,
France). Natural α-cyclodextrins (α-CD), β-cyclodextrins (β-CD) and γ-cyclodextrins (γ-CD) were
provided by Wacker (München, Germany) and permethylated β-CD [PMβ-CD] by Roquette (Lestrem,
France). Homopolymers, terpolymers and tetrapolymers of CD, were acquired from start-up In-Cyclo
(Rouen, France). The surfactant Sodium Lauryl Sulfate (SLS) was obtained from VWR (Radnor, PA,
USA). All other chemicals and the reagents were commercially available products of analytical grade.
2.2. Amphotericin B Determination-HPLC/UV Method
AmB was analyzed, isolated and quantified using an HP 1100 series chromatographic system
(Agilent Technologies, Santa Clara, CA, USA) equipped with a binary pump, an auto sampler and
a diode array detector with a detection wavelength set at 405 nm. The separations were performed
on a base-deactivated reversed phase Purospher® Star RP-C18 column (Merck Chemicals, Belgium).
The elution was realized by a mobile phase composed of MeOH/Acetonitrile /EDTA 0.25 mM buffer
(40:30:30) (v/v/v), running at a flow rate of 1 mL/min. The injected volume was 10 µL and the column
temperature was set at 25 ◦C during the analysis time. The LC-method was used for the solubility and
lyodisponibility studies of the pure drug and the different matrix loaded with AmB.
2.3. Synthesis of Homopolymers, Terpolymers and Tetrapolymers of CD
Cyclodextrin polymers were synthesized by using a direct melt polycondensation process
according to the method reported by Skiba [18]. Briefly, a mixture of known amount (w/w) of
cyclodextrins (α, β, γ or per-methyl β), citric acid and sodium phosphate dibasic was transferred into
a reactor which was maintained at temperature ranging between 140 ◦C and 150 ◦C for fixed time.
The obtained solid form was dissolved in water and dialyzed using polyether sulfate membrane filter
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with molecular weight cut off of 10,000 Da. After the dialysis, the resulted solution was spray-dried
with a Mini Spray Dryer B-290® (BÜCHI, Flawil, Switzerland).
2.4. Phase Solubility Studies
The experiments were in accordance to Higuchi & Connors [20] to evaluate the interactions
between AmB and the cyclodextrin entity in terms of solubility. The different Poly-CD: Poly γ-CD
(homopolymers), Poly αγ-CD and Poly βγ-CD (terpolymers) and Poly αβγ-CD (tetrapolymers) were
solubilized in flask that containing 5 mL of distilled water. An excess amount of AmB was added in the
saturation limit. The yellow-orange suspensions were magnetically stirred at 600 rpm at T = 37 ± 2 ◦C
for three days and centrifuged at 10,000 rpm by Eppendorf 5800 Centrifuge (Hamburg, Germany).
Finally, the supernatant fluid was filtered (0.2 µm) and analyzed by HPLC. The concentration range
was between 25 and 1000 mg/mL for Poly-CD in accordance to their higher limit solubility which
fixed at 1.2 g/mL [17].
2.5. Preparation of Amorphous Solid Dispersions
A Büchi 290 nozzle type mini spray-dryer (Flawil, Switzerland) was used for the preparation
of AmB-loaded spherical amorphous solid dispersions. The cyclodextrin polymers used as
homopolymers poly γ-CD, terpolymers poly αγ-CD and poly βγ-CD and tetrapolymer αβγ-CD are
retained because of their greater ability to solubilize AmB and based on the results of phase solubility
studies. The conditions of spray-drying were determinate by an optimization within the laboratory.
Amorphous solid dispersions were prepared with Poly-CD dissolved in 270 mL of deionized water
(DW). The AmB powder was solubilized in 30 mL of methanol and sonicated for 10 min. The yellow
and cloudy solution of AmB was added in polymer aqueous solution and stirred mechanically for
15 min to allow a better dispersion of AmB in the mixture. The amorphous solid dispersions with
AmB content (approximately 1%, 7%, 15%) were prepared by spray-drying. The same method was
used to prepare inclusion complexes based natural γ-CD.
The amorphous solid dispersions were prepared from a lower AmB loading concentration than
the equilibrium solubility of AmB in cyclodextrin polymers. The solutions were spray-dried with
solution feed rate of 4 mL/min and outlet temperature of 130 ◦C. The inlet temperature was observed
in the domain of 75–80 ◦C. The pressure of the aspirator filter vessel was maintained between P values
of −50 and −40 mbar.
The formed solution or suspension was left under magnetic stirring throughout the process of
atomization by spray-drying. A homogeneous powder was obtained at the end of the process.
2.6. Drug Loading and Entrapment Efficiency
The dosage of AmB in the different formulations was carried out by HPLC to estimate the
amount present in each powder and to determine the efficiency of the atomization process. Besides,
the homogeneity of AmB distribution in the matrix was verified by a triplicate analysis of the powder
samples (n = 3). An equivalent of 50 mg of AmB were solubilized in 5 mL DMSO and completed to
100 mL by a mixture contained (H2O:methanol) (80:20) (v/v). The solution was sonicated and filtered
through 0.45 µm PVDF, diluted and analyzed by HPLC.
2.7. Evaluation of Aggregated States of AmB by Spectrophotometry UV
An equivalent of 1 mg of AmB was prepared from the amorphous solid dispersions
(Poly γ-CD:AmB) in distilled water to obtain a concentration of 10 µg/mL, and analyzed by UV-1600PC
UV/vis spectrophotometer (VWR, Radnor, PA, USA) using a quartz cell in the range of 300–450 nm.
The same concentration of cyclodextrin polymers (Poly γ-CD) without AmB was used as blank.
The UV spectrum of AmB pure drug, and AmB in polymeric matrix were compared with literature
and marketed formulations.
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2.8. Differential Scanning Calorimetry Property
Differential scanning calorimetry (DSC) was performed using DSC6® (Perkin-Elmer, Waltham,
MA, USA). An empty aluminum pan was used to calibrate the apparatus. Samples (containing 5 mg of
amphotericin B) were accurately weighed into aluminum pans and sealed. Sample thermograms were
obtained at a scanning rate of 10 ◦C/min conducted over a temperature range of 30–250 ◦C under
a nitrogen gas (30 mL/min). The apparatus was controlled by the Pyris® software (Perkin-Elmer,
Waltham, MA, USA). Measurements were performed in triplicate.
2.9. Thermal Analysis
Mass losses were recorded with 4000® (Perkin-Elmer, Waltham, MA, USA) on 5 mg samples in
open pans at the heating rate of 10 ◦C in the 30–700 ◦C temperature range under a nitrogen gas flow
(20 mL/min). All measurements (AmB pure drug, Poly-CD, Physical mixture and amorphous solid
dispersions) were performed in triplicate.
2.10. Fourier Transformed Infrared Spectroscopy (FT-IR)
The interaction of AmB with natural CD and Poly-CD in the solid state from dried samples were
studied by infrared spectroscopy. FT-IR spectra were recorded on an IR spectrophotometer from
PerkinElmer equipped with an ATR, in the range between 4000 cm−1 and 700 cm−1 at a resolution of
8 cm−1 and with 20 scans. All measurements were performed in triplicate.
2.11. Raman Spectroscopy Property
Raman analyses were carried out by using a confocal Raman microscope (Lab Ram HR by
Jobin-Yvon Horiba, Kisshoin, Minami-ku Kyoto 601-8510, Japan). The excitation of Raman scattering
was operated by a He-Ne laser at a wavelength of 632.8 nm. The spectral resolution used was 2 cm−1.
Raman spectra of the crystals with good signal-to-noise ratio was obtained with integration times from
30 to 90 s and the duration of the data collection was adjusted in order to minimize the background
signal. The selected spectral lateral resolution was 4 cm−1 for a spatial lateral resolution better than
2 mm. All experiments were carried out at room temperature.
2.12. Particle Size Analysis
The measurement of particle size was performed using Malvern Mastersizer (Malvern Hydro
2000S, Grovewood Road Malvern WR14 1XZ, United Kingdom). Heptane was used as a dispersant
(refractive index of 1.385–1389 and polarity index of zero) [21]. Each sample was dispersed in heptane
and stirred at 2000 rpm in order to reduce the interparticle aggregation. The obscuration range
was maintained between 10–20%. The average particle sizes were measured after performing the
experiment for each batch in triplicate.
2.13. Scanning Electron Microscopy (SEM)
A Scanning electron microscopy (model JEOL JCM-5000, Musashino, Akishima, Tokyo 196-8558,
Japan), NeoScope instrument was used for the study at an accelerated voltage between 10 and 15 kV.
Powder samples were stuck on SEM stub with conductive adhesive tape and coated with gold to
reduce electric charges induced during analysis with a NeoCoater MP-19020NCTR.
2.14. In Vitro Dissolution
In vitro dissolution studies of pure drug and solid dispersions prepared by the different methods
were evaluated using Vankel VK 7000® dissolution system (Varian Inc., Palo Alto, CA, USA).
The rotation speed was 75 rpm and the temperature were adjusted at 37 ◦C ± 0.5 ◦C.
The drugs prepared by spray-drying were tested in two different media with 0.10% (m/v) of
SLS. The first was an acid medium at pH = 1.2 for the prediction of release capability in vivo using
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simulated gastric medium. The second was at pH = 7.4 having a similarity with simulated body
fluid [22]. The composition of both dissolution media was:
Dissolution medium [1]: 7 mL of HCl (37%) was added in a 1-L flask containing 500 mL of water.
2 g of NaCl was added and the volume was completed to 1000 mL with H2O and pH adjusted to a
value of 1.2 with HCl 0.1 M.
Dissolution medium [2]: the components described in Table 1 were simultaneous solubilized
in 500 mL of H2O, the volume was completed to 1000 mL with H2O and pH adjusted to a value of
7.4 with HCl 0.1 M. The equivalent of 5 mg of AmB was predetermined and dissolved into vessels
containing 250 mL of dissolution medium in compliance with sink conditions. SLS was selected as
detergent for the dissolution test because of his strength ionic power in saline solution.
Table 1. Dosage (%) and mean diameter particles of amphotericin B drug (AmB), and different
spray-dried formulations: solid dispersions (SD), γ-cyclodextrin based polymers (Poly γ-CD) and
αγ-cyclodextrin based polymers (Poly αγ-CD). 95% limits mean the limits of size of 95% of the
particle populations.
Formulations/(%)
MeOH
Dosage
(%)
Mean
Diameter (nm) Sd (nm)
95% Limits
(nm)
Indice of
Polydispersity
Amphotericin B - 7090 370 5560–8630 1.6
AmB spray-dried
(sd)/10% - 11,200 605 8130–14200 1.4
AmB spray-dried
(sd)/50%MeOH - 19,500 643 12,500–2,6500 0.8
SD (Poly γ-CD/AmB)
(100:20)/10% 13.72% 1170 46 1060–1270 1.2
SD (Poly γ-CD/AmB)
(100:10)/10% 5.19% 688 24 641–734 1
SD (Poly γ-CD/AmB)
(100:10)/30% 5.39% 1820 52 1620–2020 1.1
SD (Poly αγ-CD/AmB)
(100:20)/10% 13.17% 3620 106 3060–4190 1.2
SD (Poly αγ-CD/AmB)
(100:1)/10% 5.27% 1550 47 1400–1710 1.2
SD (Poly αγ-CD/AmB)
(100:10)/50% 8.37% 5640 221 4550–6730 1.2
SD (Poly γ-CD/AmB)
(100:10)/50% 8.36% 5450 218 4420–6490 1.2
In all experiments, 2 mL of dissolution sample was withdrawn at 5, 10, 20, 30, 45, 60 and 90 min and
replaced with an equal volume of the fresh medium supplemented with 0.1% or 0.02% SLS to maintain
a constant total volume. Samples were filtered through 0.20 µm and assayed for drug content at 405 nm
by UV spectrophotometry. The dissolution tests were conducted in triplicate (n = 3). Cumulative
percentages of dissolved drug from preparations were calculated using calibration equations.
3. Results and Discussion
3.1. Drug Solubility Study
The first step for the design of a potential efficient formulation based on the use of cyclodextrins is
to determine the impact of cyclodextrins or their derivatives on AmB solubility. A HPLC/UV method
was developed and validated in terms of specificity, precision, accuracy and linearity. The analytical
method proved to be linear over the concentration range of (0.5–50) µg/mL on three days (n = 9)
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in agreement with ICH guidelines (ICH-Q1-R2) [23] The chromatographic separation was obtained
at 12 min. using the described method and the chromatographic parameters were summarized in
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and Poly αβγ-CD, Poly αβγ-CD chitosan poly ers (cyclodextrin tetrapoly ers) ere synthesized
according to the organic solvent-free method reported by Skiba et al. [18]. We tested a lot of
different Poly-CD, because drug interactions with such polymers could interact through inclusion in
cyclodextrin cavities but also through poly er adsorption or inclusion in cavities bet een poly er
ra ifications. Thus, it is difficult to extrapolate that the best inclusion complexation with a determined
native cyclodextrin leads to the best complexation with its polymerized form. From results of AmB
solubility studies, Poly γ-CD showed the best enhancement with an increase of AmB solubility
multiplied by a factor 127 to reach 761 µg/mL. An i portant interaction was also observed between
polyene and terpolymers (Poly αγ-CD and Poly βγ-CD) increasing the solubility to 463 µg/mL and
461 µg/mL, respectively. Only with polymers containing γ-CD in their composition as Poly αβγ-CD,
a minor improve ent of AmB solubility was remarked, while no improvement was shown using other
Poly-CD: Poly αβ-CD, Poly α-CD, Poly β-CD or poly per-Me β-CD. The solubility of AmB molecules
was significantly increased only when γ-CD were mostly used as complexing agent. Poly-CD are high
hydrophile polymers without hydrophobic block [19]. There are, thus, no amphiphile substance such
as PEG-PLGA allowing the formation of micelles to improve the solubility of AmB [24]. The core of
CD has hydrophobic properties but the outside of CD is high hydrophilic due to their -OH functions.
This explains why these results demonstrate that increasing solubility was a consequence of more
interactions through hydrogen bonds leading to inclusion complexation in cyclodextrin cavity. An easy
substitution of water molecules by AmB is due to the polar–apolar energy through hydrogen bonds
or Van der Waals interactions and to the reduction of intermolecular interactions responsible for low
solubility. This could also be due to the esterification of AmB hydroxyl, amine or carboxyl group by
the presence of citric acid within the polymeric structure [17].
3.2. Characterization of Designed Formulations
Several characterizatio s of the different designed formulations were performed and compared
to AmB free form in order to better understand the influence of formulation on physico-chemical
properties and interactions between γ-CD (or derivatives) and AmB.
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3.2.1. Amphotericin B Content
The quantification of AmB within the different formulations using chromatographic validated
method was given in the Table 1, as well as the mean diameter of powders. All the formulations
prepared by spray-drying were found to be monodisperse. Drug content ranged from 90.0% to 100.0%
with a homogeneous distribution of AmB in the powder (n = 3). Low coefficient of variance (CV) values
(<1.0%) in drug content indicates the reproducibility of the technique employed for the preparation
of solid dispersion (SD). The spray-dried powders were produced at different yields where the mass
quantities found were higher than 45%.
3.2.2. Morphology and Particle Size Analysis
The results are summarized in Table 1. The particles of free form AmB have an average size in
the micrometer range, 6–8 µm. By comparison, the average size of AmB particles obtained from a
spray-dried water–methanol solution was between 8 and 26 microns. This size difference could be
due to the limited solubility of AmB in methanol/water mixture, resulting in agglomeration of AmB
molecules. Size comparison between the different formulations containing CDs polymers shows that
the formulations based on γ-CD homopolymers have a smaller average size that can enhance their
wettability. PDI values >1 indicate a polynomial population of particles which can be explained by the
presence of free amphotericin B in micelle form.
In Figure 2 shows SEM micrographs of spherical amorphous solid dispersions, revealed clear
changes in the morphology of powder particles with evident formation of spherical amorphous
solid dispersions.
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3.2.3. Differential Scanning Calorimetry Analysis
The Differential Scanning Calorimetry (DSC) curve of free form AmB showed a sharp endothermic
peak at T = 174 ◦C corresponding to its melting point and suggesting its crystalline nature, followed by
a glass transition temperature (Tg) at T = 200 ◦C [25]. However, in the physical mixture, a double pic
can be observed: one corresponding to the polymer and one indicating a presence of crystalline form of
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amphotericin B. This second pic is displaced towards a lower temperature and the broadening can due
to a weak interaction. Concerning the thermal comportment of AmB, a new peak of solid dispersion
appeared corresponding to a new entity formed as a consequence of the interaction between AmB and
γ-CD polymeric network and cavities (Figure 3).
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The disappear nce of the AmB endothermic peak was a strong evidence of an amorphous
transformation that is favorable to rapid bioavailability during in vivo drug release.
3.2.4. Thermal Analysis
The thermal analysis of solid dispersion is shown in Figure 4. AmB showed critical weight loss
that is stabilized aroun 600 ◦C. This is probably related to the decomposition of AMB structure.
The lost weight indicates the loss of wat r m lecul s included in CD cavities. Poly γ-CD presented
three stages of weight loss. The weight loss percent fo amphotericin B (A B), physical mixture and
solid dispersions (SD) based AmB and γ-cyclodextrin polymers (Poly γ-CD) were iven in Table 2.
Previous studies have reported the pr sence of water molecules, depen ing on the relative humidity in
CDs [26]. For the spherical amorphous solid dispersion, the thermogram was different from the pure
materials. This demonstrated the occurrence of interactions between the drug and carriers leading to
the formation of new system. This present study also showed that the dehydration pattern of solid
dispersion was different from the thermal behavior of pure CD and physical mixture. The percentages
of water evaporation decreased when the complex was formed, this fact could be explained by the
substitution of water molecules by AmB in one hand, and by the solid dispersion method itself that
eliminate host water molecules, in other hand.
Table 2. Weight loss in percent of amphotericin B (AmB), physical mixture and solid dispersions
(SD) based AmB and γ-cyclodextrin polymers (Poly γ-CD) calculated from the dehydration step of
thermal analysis.
Analyzed Products
Dehydration Step
Temperature Range (◦C) Weight Loss (%)
Amphotericin B 30 105 3.40
Poly γ-CD 30 105 5.69
Physical Mixture 30 105 5.60
SD [Poly γ-CD/AmB] 30 105 1.87
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3.2.5. Infrared and Raman Spectroscopy Property
The spectra of active ingredient showed the presence of a characteristic peak (Table 3) [27].
A broad absorption band connected to a strong bond corresponding to a νOH stretching vibration that
explains the presence of intermolecular hydrogen bonds between molecules of polyene [24].
Table 3. Characteristic bands of amphotericin B in infrared spectroscopy.
C mpound Absorption (cm−1) Nature of Bond Typ of Vibration
Amphotericin B
1557.8 cm−1 δsN–H (in the plan) Deformation
1590 cm−1 νC–C Stretching
1690.17 cm−1 νasC=O [COOH] Stretching
2934.5 cm−1 νs+as [CH2, CH3] Stretching
3360.6 cm−1 ν[CH] polyene Stretching
The interactions between γ-CD and AmB were studied by infrared spectroscopy. The elongation
of the absorption band at 1020 cm−1 characteristic to the β-glycosidic linkage and the disappearance
of the absorption bands at 1396 cm−1 could translate the interaction of AmB with the hydrophobic
cavity of γ-CD via a C–H bond. An increase in intensity and a slight shift of the absorption band
between 3000 and 3500 cm−1 was observed and that could be explained by the host–guest interactions
as a consequence of water release upon inclusion. The disappearance of characteristic bands of AmB
(N–H, and C=O) means the formation of single compound from AmB and γ-cyclodextrin as a result of
AmB inclusion in γ-CD characterized by a sufficient cavity size (approximately 8.5 Å) for receiving an
antifungal molecule (Figure 5).
About cyclodextrin polymers used, we noted a broad absorption band at 3330 cm−1 that
corresponds to the stretching vibration νOH and explains a high polymer molecular association
through intermolecular bonds between dimer entities. According to Skiba et al. [18], this interaction
is due to condensation reaction between C=O carboxylic of citric acid and hydroxyl group (–OH)
from the oligosaccharide entity (natural CD). The spectral analysis and comparison between solid
dispersion-based homopolymer CDs and physical mixture (Figure 5) were illustrated by the higher
frequency shift of the unsaturated acid carbonyl C=O stretching band from 1690 cm−1 at 1719 cm−1
in the spray-dried formulations, when it was maintained in the physical mixture. This change was
caused by decreasing the crystallinity of AmB molecules present in the polymer matrix [25].
Pharmaceutics 2018, 10, 235 10 of 18
Pharmaceutics 2018, 10, x FOR PEER REVIEW  10 of 18 
 
 
Figure 5. FTIR spectra of amphotericin B, uncharged solid dispersion of γ-cyclodextrin polymer (poly 
γ-CD), physical mixture and amorphous solid dispersion based γ-cyclodextrin polymer and AmB 
(SD poly γ-CD/AmB). 
About cyclodextrin polymers used, we noted a broad absorption band at 3330 cm−1 that 
corresponds to the stretching vibration νOH and explains a high polymer molecular association 
through intermolecular bonds between dimer entities. According to Skiba et al. [18], this interaction 
is due to condensation reaction between C=O carboxylic of citric acid and hydroxyl group (–OH) 
from the oligosaccharide entity (natural CD). The spectral analysis and comparison between solid 
dispersion-based homopolymer CDs and physical mixture (Figure 5) were illustrated by the higher 
frequency shift of the unsaturated acid carbonyl C=O stretching band from 1690 cm−1 at 1719 cm−1 
in the spray-dried formulations, when it was maintained in the physical mixture. This change was 
caused by decreasing the crystallinity of AmB molecules present in the polymer matrix [25]. 
The spectral translation of the solid dispersion-based Poly γ-CD was essentially manifested by 
a great reduction or disappearance of the band at 3360.5 cm−1 corresponding to the OH stretching 
vibration and strong hydrogen bonds [OH…HO], that can be explained by the dissociation of 
intermolecular hydrogen bonds between the molecules of the AmB, and suggesting a monomeric 
AmB dispersion in the matrix. This phenomenon was absent in the inclusion complex with γ-CD. 
Another band was disappeared at 2930 cm−1 (CHalkyl) in the SD when this loss was not remarked in 
the IC containing Is the space necessary? CD suggesting a difference of AmB interaction between the 
γ-CD and the poly γ-CD. 
The Raman spectroscopy analysis of pure AmB presents three bands at 1001.8 cm−1, 1155 cm−1 
and 1559 cm−1, corresponding to C–C–H, C=O and C=C, respectively (Figure 5) [9,10]. Principally, the 
comparison between the Raman spectra of amphotericin B, physical mixture (PM) and solid 
dispersion (SD) were distinguished by a modification at spectral regions concerning polyenic 
vibrations (Figure 5). A first major change was reflected by an increase in the peak intensity 
characteristic to AmB C–CH bonds in the SD and IC that could be explained by the inclusion of AmB 
in the solid matrix [28]. This interaction was not observed in the physical mixture. The shift to lower 
frequency by a wavenumber of 3 cm−1 of the principal band from 1559 cm−1 to 1556 cm−1 was resulted 
to the delocalization of π electron system caused by the broadening from the 1535 to 1556 cm−1, 
indicating an AmB crystallinity decrease. The transformation was approved by the strong decrease 
of the band at 1008 cm−1 of infrared spectroscopy (Figure 5). 
Those changes reflect the amorphous transformation of AmB molecules in the polymeric 
dispersion [29]. The differentiation between the inclusion complex, the solid dispersion based on γ-
CD entities and γ-CDs homopolymer was mainly expressed by the band widening between 1535 cm−1 
Figure 5. FTIR spectra of amphotericin B, uncharged solid dispersion of γ-cyclodextrin polymer
(poly γ-CD), physical mixture and amorphous solid dispersion based γ-cyclodextrin polymer and
AmB (SD poly γ-CD/AmB).
The spectral translation of the solid dispersion-based Poly γ-CD was essentially manifested by
a great reduction or disappearance of the band at 3360.5 cm−1 corresponding to the OH stretching
vibration a d str ng hydrogen bonds [OH . . . HO], that ca be expl ined by the dissociati of
intermolecular hydroge bonds between the molecules of the AmB, n suggesting a monomeric AmB
dispersion in the matrix. This phe omenon was ab ent in the inclusion co lex with γ-CD. Another
band was disappeared at 2930 cm−1 (CHalkyl) in the SD when this loss was not r marked in the IC
containing Is the space necessary? CD suggesting a difference of AmB interaction between the γ-CD
and the poly γ-CD.
The Raman spectroscopy analysis of pure AmB presents three bands at 1001.8 cm−1, 1155 cm−1
and 1559 cm−1, corresponding to C–C–H, C=O and C=C, respectively (Figure 5) [9,10]. Principally,
the comparison between the Raman spectra of amphotericin B, physical mixture (PM) and solid
dispersion (SD) were distinguished by a modification at spectral regions concerning polyenic vibrations
(Figure 5). A first major change was reflected by an increase in the peak intensity characteristic to
AmB C–CH bonds in the SD and IC that could be explained by the inclusion of AmB in the solid
matrix [28]. This interaction was not observed in the physical mixture. The shift to lower frequency
by a wavenumber of 3 cm−1 of the principal band from 1559 cm−1 to 1556 cm−1 was resulted to the
delocalization of pi electron system caused by the broadening from the 1535 to 1556 cm−1, indicating
an AmB crystallinity decrease. The transformation was approved by the strong decrease of the band at
1008 cm−1 of infrared spectroscopy (Figure 5).
Those changes reflect the amorphous transformation of AmB m lecules in the polymeric
dispe sion [29]. The differentia ion between the inclusion complex, the solid dispersion based o γ-CD
entities and γ-CDs homopolymer was mainly expressed by the band widening b tween 1535 cm−1 to
1556 cm−1 n the solid dispersion mea ing a transfo mation of crystalline AmB to amorphous state
while it did not ppear in th inclusion complex spectra alysis (Figure 6). Another important shift to
a lower frequency from 1559 cm−1 to 1556 cm−1 in both formulas means that AmB was not included
only in the cavities of the γ-CD but also dispersed in polymeric networks [30].
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3.2.6. ggregation Studies by V
The state of B olecule aggregation ithin the solid dispersion as studied in order to
obtain ore infor ation on the aggregation state present in the developed for ulation for a possible
prediction of their efficacy and toxicity [15]. The spectrophoto etry of B absorbance ay reveal
both the B olecular for present in the aqueous ediu and the confor ational state of such
olecules. Those conformations are responsible of efficacy and toxicity. In addition, the influence
of other constituents on different AmB aggregation states has been studied to found the ore stable
for [31]. Free amphotericin B cannot be completely dissolved in water during our aggregation studies.
Methanol was used to obtain a solvent (MetOH:water 1:1) able to dissolve the free form of this drug.
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This solvent was the same for all studied formulations and, therefore, induced the same potential
alteration of drug interaction with polymer.
The UV spectrum of AmB in MeOH/H2O mixture at approximately 10 µg/mL was principally
represented by the presence of four bands, one at 347 nm followed by three well-separated bands
at 364 nm, 384 nm and 408 nm (Figure 7). The last one was considered as the principal absorption
confirming the great presence of AmB monomer form and different aggregate forms [32,33]. In the
literature, the spectrum of Fungizone® showed an intense broad peak at 329 nm and a lower absorption
for the other peaks resulting in the self-aggregation of AmB [16]. The increase of AmB concentration
was revealed by the improvement of the first band at 347 nm and the apparition of another band at
421 nm suggesting the high aggregation of AmB in aqueous solution [32].
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The UV spectrum of AmB in MeOH/H2O mixture at approximately 10 µg/mL was principally
represented by the presence of four bands, one at 347 nm, followed by three well-separated bands at
364 nm, 384 nm and 408 nm (Figure 7).
The analysis of the obtained spectru can be used to determine a ratio between Peak I and peak
IV considered as an index of relative aggregation state. The index of AmB and Fungizone® was equal
at 0.28 and 3.7, respectively.
The electronic absorbance of amorphous Poly γ-CD solid dispersion was illustrated by the
presence of the three bands at 365 nm, 384 nm and 408 nm showing the great presence of monomeric
AmB [4]. The lack of those bands (329 n and 421 nm) can indicate that the AmB has a good
monomeric distribution within the polymeric network, was generally in monomer form and may
present also in the dimeric form so the most preferred aggregation state in terms of drug action
and toxicity [16,32]. In aqueous medium, the dimerization by the association of AmB monomers
was quickly established before the aggregation in water. The dimers in their different assemblage
(parallel and anti-parallel) were stabilized by Van der Walls interactions also hydrophobic interactions
responsible for aggregation [33–35]. The dimerization and aggregation phenomena were prevented
by Poly γ-CD and the AmB monomers present in the mixture. The distribution of AmB in aqueous
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solutions at over a critical concentration (at C > 10−7 M) was distinguished by the presence of three
different shape balances. These forms were dependent to the AmB concentration, the medium of
solubilization and the action of the solid matrix. The highest toxicity was caused by the aggregates,
less toxicity was obtained by the oligomer, essentially a dimeric form while the best antifungal active
form was the AmB monomer that reduces the renal toxicity [32], demonstrating the utility to design
AmB in solid dispersion with Poly γ-CD as matrix.
3.3. In Vitro Dissolution Study
The dissolution study compared to drug in free form is one of the crucial tests to obtain information
about predicted in vivo behavior of designed formulations and their contained drug. The dissolution
studies of AmB alone, and AmB included in solid dispersion at simulated gastric fluid (pH = 1.2) was
remarked by the diminution of present quantity in the medium due to the degradation caused by the
acid catalysis [36]. While the dissolution of AmB from the SD at pH = 7.4 was completely done after
45 min, it was not valid for the pure drug where only 60% was entirely dissolved (Figure 8).
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At a low surfactant concentration (0.02% w/v), the dissolution profile of the SD at high A B
loading (approximately 15%) was rapid and 30-times greater than the AmB alone after 120 min.
At a higher surfactant concentration (0.1% w/v), a rapid release profile was obtained for SD-based
ho opoly er-CD dispersions with complete dissolution at 40 min while at the same o ent, only 40%
of AmB in free form was dissolved (Figure 9). Increasing the amount of ethanol in the initial
co position of the for ulations induced larger particles, leading to both a reduce ettability and
delayed dissolution profiles.
The co parison of the dissolution curves of γ-CD and Poly γ-CD entities gives crucial information
about the AmB distribution in these two different matrices. A complete release achieved within 40 min
as observed for the solid dispersions that proves the presence of monomeric dispersion of the
AmB. This was the consequence of more interactions between AmB and Poly γ-CD, probably due to
H-binding with acid functions of citric acid. With γ-CD, only drug interactions with the hydrophobic
cavities of cyclodextrins could be performed, limiting the number of host molecules in this matrix.
Hence, the presence of an excess of AmB in an aqueous medium gives rise to the dimerization of the
Pharmaceutics 2018, 10, 235 14 of 18
polyenes between them through intermolecular interactions, preventing dissolution. This explains
why only 65% of the AmB were dissolved even after 2 h with inclusion complexes formulation.
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Figure 9. Dissolution profiles of AmB, solid dispersions (SD) with different polymers composition
(αγ-poly CD, γ-poly CD) and inclusion complex (IC) in simulated fluid medium pH = 7.4 with 0.02%
(A) or 0.1% SLS (B).
For the same AmB amount loading (approximately 15%), the difference between the IC (γ-CD:
AmB) and ASD (based Poly γ- or Poly αγ-CD) was cl arly observ (Figure 10). At 20 min, only half
of the present AmB quantity was dissolved from the IC compared to the ASD. Additionally, the AmB
from the different ASD was completely dissolved after 45 min. This is due to the go d exposition of
AmB particles to the dissolution m dium because of the difference in dr g loading and the fact that
the CD polymers allow a good wettability of AmB particles whi h are well dispersed in the sys em.
So, the poly eric structure ffers to the antifungal drug th poss bility of state change and d creasing
crystallinity, p eventing the polyenic molec lar association and permitting a good dissolution due
to good exposition particle size r ducti n. These results could be expla ed by a better dispersion of
AmB monomers in the polymeric structure.
The physical mixture demonstrated a slight interaction between AmB and CD polymers by DSC
that was confirmed by the significance of spray-drying process in th dissolution com rt ent in terms
of the elimi ation of residual humidity and amorphous change state (Figure 10). The importance of
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the atomization at high pressure and temperature was confirmed by the rapid dissolution spray-dried
AmB (56% reached at 15 min compared to 30% for AmB bulk).
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Figure 10. Dissolution profiles of cyclodextrin terpolymers (βγ-CD, αγ-CD) for different methods of
preparation (A). Comparison of dissolution profiles between the different spray-dried formulations
solid dispersions (SD), AmB: bulk and spray-dried, physical mixture (Phys. Mix) (B).
The dissolution behavior of solid dispersions was impacted by the choice of polymer compound
and its composition in natural cyclodextrin, the ratio of AmB in the powder and spray-drying
processing conditions. Even the slight difference in terms of solubility between γ-CD and the polymer
of γ-CD, the advantages of polymeric structure were observed in dissolution studies, and AmB
onomeric structure within polymers in the solid state. The fundamental properties of CD polymers
were expressed in a different behavior in the solid state. An amorphous state is obtained by the
spray-drying technique where during atomization, the H2O molecules were discarded and AmB
molecules were placed in the dense polymeric network. The result was confirmed by the inability
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to charge the γ-CD in the solid state even after atomization. In spite of the strongest Van der walls
interactions in the solid state because the shortness of distance, γ-CD polymers have a capacity of
offering a good AmB distribution to decrease the aggregation phenomena.
4. Conclusions
The concept of spherical amorphous solid dispersions 4.0 brings an interesting formulation
alternative with the use of innovative Poly-CD. Indeed, this allows us to develop powders having high
AmB monomers loading (15% (w/w)) in comparison to inclusion complex with natural cyclodextrin.
The solid particles were advantageous for the improvement of the dissolution profile (100% at 40 min
at pH = 7.4) through the solubility increase, as well as the reduction of the particle size allowing good
wettability of particles in dissolution. Also, the controlled release can be obtained by this 4th generation
of solid dispersions [17]. Furthermore, the synthesis process of different polymers of cyclodextrins as
described by Skiba et al. [18] is simple, rapid and without organic solvent, and their biodegradable
composition may offer a human use possibility. The physicochemical properties and the behavior of
AmB in the polymeric matrix were demonstrated by spectroscopy. The infrared spectroscopy gives us
an idea about the interaction between the polyene and oligosaccharide of cyclodextrin. The inclusion
of AmB within the cavities was also confirmed. This was confirmed by both, (i) the low waters
quantities present in the spray-dried formulations as a consequence of water molecules substitution
in the inner cavity of CD, and (ii) the decrease with Poly-CD of AmB crystallinity observed by DSC,
Raman and infrared spectroscopy. The amphotericin B amorphization was probably a consequence of
its interaction with Poly-γ-CD by dipole–dipole interactions and without a creation of covalent binding
with the host molecule because the drug release was facilitated by the binary matrix. The spray-dried
amphotericin B amorphous solid dispersions 4.0 technology showed, in consequence, the possibility of
drug development for oral utilization or as powder aerosols for pulmonary administration.
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